Key Takeaways: Cure 4 The Kids Foundation never denies care to a child with cancer for any reason Our open-access pediatric oncology model means treatment
Key Takeaways: The United Nations is poised to formally recognize childhood cancer in its Fourth High-Level Meeting on Non-Communicable Diseases—a historic first that could reshape
Key Takeaways: What are the AKAC and GKAC Acts? Two bipartisan federal bills working to remove systemic barriers in pediatric cancer and rare disease care
Key Takeaways: Nevada receives among the lowest NIH funding in the nation—ahead of only Alaska and Wyoming—making our research ecosystem especially vulnerable to federal cuts.
Key Takeaways: Participants ranged from patient families to caregivers to community organizations, embodying the spirit of Southern Nevada’s support for childhood cancer care For the
Key Takeaways: Nevada’s Rare Disease Advisory Council (NV-RDAC) has launched comprehensive Patient & Family and Healthcare Provider Needs Assessments to gather critical insights about rare
Key Takeaways: Nevada passed two major rare disease bills in 2025: SB189 (genetic counseling licensure) and SB348 (newborn screening modernization). SB189 establishes licensing for genetic
Key Takeaways: Childhood cancer typically results from random genetic mutations that occur during rapid cell growth and development, not from lifestyle or environmental factors. Most
Key Takeaways: On September 30, 2025, the U.S. Department of Health and Human Services announced a decision that will reshape the future of pediatric cancer